Jacob Boyd
Dermatology · Corvallis, ORNPI 1417692633
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations.
Across 224 payments — averaging $29.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Novartis$529
- Sanofi$467
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$306
- Dermavant Sciences, Inc.$299
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$2193%
- Food & beverage$6,02792%
- Education$3095%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,446 |
| Johnson & Johnson | 63 | $1,296 |
| Novartis | 12 | $529 |
| Sanofi | 21 | $467 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $306 |
| Dermavant Sciences, Inc. | 4 | $299 |
| E.r. Squibb & Sons, L.L.C. | 4 | $298 |
| Regeneron Healthcare Solutions, Inc. | 10 | $290 |
| Lilly USA, LLC | 11 | $245 |
| Galderma Laboratories, L.p. | 3 | $210 |
| UCB, Inc. | 8 | $208 |
| Boehringer Ingelheim | 4 | $161 |
| Janssen Scientific Affairs, LLC | 2 | $160 |
| Arcutis Biotherapeutics, Inc. | 2 | $133 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Sun Pharmaceutical Industries Inc. | 2 | $69 |
| Biofrontera Inc. | 3 | $63 |
| Organon | 2 | $57 |
| Pfizer | 2 | $50 |
| LEO Pharma Inc. | 2 | $39 |
| Sandoz | 1 | $35 |
| Amgen | 1 | $34 |
| Blueprint Medicines Corporation | 1 | $23 |
| Incyte Corporation | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| CSL Behring | 1 | $17 |
| Mylan Institutional Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,555 in reported general payments places this provider in the 80th percentile of 175 dermatology providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $59,895 |
| Clobetasol Propionate | 69 | $2,020 |
| Tacrolimus | 17 | $1,528 |
| Fluorouracil | 18 | $1,073 |
| Ketoconazole | 72 | $1,010 |
| Triamcinolone Acetonide | 58 | $720 |
| Doxycycline Monohydrate | 19 | $561 |
| CiclopiroxCiclopirox Olamine | 13 | $379 |
| Hydrocortisone | 22 | $141 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Corvallis
- Adriana BruneCorvallis$11K
- Sterling FarrerCorvallis$10K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.